Novel oral anticoagulants work as well as warfarin

organ and tissue donation: hands holding red heart
Clinical trials have shown that novel oral anticoagulants (NOACs) are as efficacious as warfarin in reducing the risk of stroke in patients with atrial fibrillation, reports the MJA. Notwithstanding, the reaserchers say that concerns remain regarding the efficacy of NOACs in real life situations, given the study looked at patients older than 75 with other

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Small weight loss may mean big benefit: study
Next Practice incentives for pharmacists in general practice: is it time to take the leap?